Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults
Clinical trial NCT04445389 · TERMINATED
Trial details
- NCT number
- NCT04445389
- Sponsor
- Genexine, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-17
- Primary completion
- 2020-12-17
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.